Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/test-epi-composition/ and changes regularly. See the Directory of published versions
Full name:
Authorised dose form:
Legal status of supply:
Domain:
Resource status:
Product classification:
Document Details
Generated Narrative: Bundle TEST PURPOSES ONLY - spedra
Language: en
Profile: Bundle - ePI
Final Document at 2022-02-16 13:28:17+0000 by Organization ACME industry for Bundle: identifier = http://ema.europa.eu/identifier#None; type = document; timestamp = 2023-06-27 10:09:22+0000
Document Subject
Generated Narrative: MedicinalProductDefinition mp67eb9f5d8991acd60b19f2204c2773c0
identifier: http://ema.europa.eu/identifier
/EU/1/13/841/001-003
type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: Spedra 50 mg tablets
type: Full name
part
part: nan
type: Invented name part
part
part: nan
type: Scientific name part
part
part: nan
type: Strength part
part
part: nan
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language EU EU en
Document Content
Generated Narrative: Composition composition-en-67eb9f5d8991acd60b19f2204c2773c0
Language: en
Profile: Composition (ePI)
identifier: http://ema.europa.eu/identifier
/EU/1/13/841/001-003
status: Final
type: Package Leaflet
category: Raw
date: 2022-02-16 13:28:17+0000
author: Organization ACME industry
title: TEST PURPOSES ONLY - spedra
Mode | Time |
Official | 2022-02-16 13:28:17+0000 |
What is in this leaflet
Spedra contains the active substance avanafil. It belongs to a group of medicines called phosphodiesterase type 5 (PDE5) inhibitors. Spedra is a treatment for adult men suffering from erectile dysfunction (also known as impotence). This is when you cannot get, or keep a hard, erect penis suitable for sexual activity.
Spedra works by helping the blood vessels in your penis to relax. This increases the blood flow into your penis, helping it stay hard and erect when you get sexually excited. Spedra does not cure your condition.
It is important to note that Spedra only works if you are sexually stimulated. You and your partner will still need to use foreplay to get ready for sex just as you would if you were not taking a medicine to help you.
Spedra will not help you if you do not have erectile dysfunction. Spedra is not for women.
Do not take Spedra:
Do not take Spedra if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking Spedra.
Warnings and precautions
Talk to your doctor or pharmacist before taking Spedra:
If any of the above apply to you talk to your doctor or pharmacist before taking Spedra. Check with your doctor or pharmacist if you are not sure.
Problems with your sight or hearing Some men taking medicines like Spedra have had problems with their sight and hearing see Serious side effects in section 4 for more details. It is not known if these problems are related directly to Spedra, other diseases that you may have or a combination of factors.
Children and adolescents
Spedra should not be taken by children and adolescents under 18 years of age.
Other medicines and Spedra
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This is because Spedra can affect the way some other medicines work. Also some other medicines can affect the way Spedra works.
In particular, tell your doctor and do not take Spedra if you are taking nitrate medicines for chest pain (angina) such as amyl nitrite or glyceryl trinitrate. Spedra has been shown to increase the effects of these medicines and severely lower your blood pressure. Also do not take Spedra if you are taking medicines for HIV or AIDS such as ritonavir, indinavir, saquinavir, nelfinavir or atazanavir or if you are taking medicines for fungal infections such as ketoconazole, itraconazole or voriconazole or certain antibiotics for bacterial infections, such as clarithromycin or telithromycin (see beginning of section 2 under Do not take Spedra ).
Tell your doctor or pharmacist if you are taking any of the following medicines:
Do not use Spedra together with other treatments for erectile dysfunction such as sildenafil, tadalafil or vardenafil.
If any of the above apply to you talk to your doctor or pharmacist before taking Spedra. Check with your doctor or pharmacist if you are not sure.
Spedra with drink and alcohol
Grapefruit juice can increase exposure to the medicine and should be avoided within 24 hours prior to taking Spedra. Drinking alcohol at the same time as taking Spedra may increase your heart rate and lower your blood pressure. You may feel dizzy (especially when standing), have a headache or feel your heart beating in your chest (palpitations). Drinking alcohol may also decrease your ability to get an erection.
Fertility
There was no effect on sperm movement or structure after single 200 mg oral doses of avanafil in healthy volunteers.
The repeated oral administration of avanafil 100 mg over a period of 26 weeks to healthy volunteers and adult males with mild erectile dysfunction was not associated with any untoward effects on sperm concentration, count, motility, or morphology.
Driving and using machines
Spedra can make you feel dizzy or affect your vision. If this happens, do not drive, cycle, use tools or machines.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. The recommended dose is a 100 mg tablet, as needed. You should not take Spedra more than once a day. You could have been given the dose of one 200 mg tablet if your doctor has decided that the mg dose was too weak for you, or the dose of one 50 mg tablet if your doctor has decided that the mg tablet was too strong for you. Dose adjustments can also be required if Spedra is used together with certain other medicines. If you are taking a medicine such as erythromycin, amprenavir, aprepitant, diltiazem, fluconazole, fosamprenavir or verapamil ( moderate CYP3A4 inhibitors ) the recommended dose of Spedra is a 100 mg tablet, with an interval of at least 2 days between doses. You should take Spedra about 30 minutes before you have sexual intercourse. Remember that Spedra will only help you to get an erection if you are sexually stimulated. Spedra can be taken with or without food; if taken with food, it may take longer to work.
If you take more Spedra than you should
If you take too much Spedra, you should tell your doctor straight away. You may get more side effects than usual and they may be worse.
If you have any further questions on the use of Spedra, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious side effects
Stop taking Spedra and see a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment:
Stop taking Spedra and see a doctor straight away, if you notice any of the serious side effects above.
Other side effects include:
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and carton after EXP . The expiry date refers to the last day of that month.
This medicine does not require any special storage condition.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
What Spedra contains
What Spedra looks like and contents of the pack
Spedra is a pale yellow oval tablet, marked 50 on one side. The tablets are provided in perforated unit dose blister packs containing 4x1, 8x1, or 12x1 tablets.
Not all pack sizes may be marketed in your country.
Marketing Authorisation Holder:
MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A.,
1, Avenue de la Gare,
L-1611 Luxembourg,
Luxembourg.
Manufacturer:
Menarini - Von Heyden GmbH Leipziger Stra e 7-01097 Dresden
Germany
or
Sanofi Winthrop Industrie 1, rue de la Vierge Ambares et Lagrave 33565 Carbon-Blanc-Cedex France
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder.
Belgi /Belgique/Belgien Menarini Benelux NV/SA T l/Tel: + 32 (0)2 721 4Lietuva UAB BERLIN-CHEMIE MENARINI BALTIC
Tel: +370 52 691
Espa a Laboratorios Menarini S.A. Tel: +34-93 462 88 Polska Berlin-Chemie/Menarini Polska Sp. z o.o. Tel.: +48 22 566 21 France MENARINI France T l: +33 (0)1 45 60 77 Portugal A. Menarini Portugal Farmac utica, S.A. Tel: +351 210 935 Hrvatska Berlin-Chemie Menarini Hrvatska d.o.o. Tel: + 385 1 4821 Rom nia Berlin-Chemie A. Menarini S.R.L. Tel: +40 21 232 34 Ireland A. Menarini Pharmaceuticals Ireland Ltd Tel: +353 1 284 6Slovenija Berlin-Chemie / A. Menarini Distribution Ljubljana d.o.o.
Tel: +386 01 300 2 sland Pharmaprim AB S mi: +46 8355Slovensk republika Berlin-Chemie / A. Menarini Distribution Slovakia s.r.o.Tel: +421 2 544 30 Italia A. Menarini Industrie Farmaceutiche Riunite s.r.l. Tel: +39-055 56Suomi/Finland Berlin-Chemie/A.Menarini Suomi OY Puh/Tel: +358 403 000
MENARINI HELLAS AE : +30 210 8316111-Sverige Pharmaprim AB Tel: +46 8355Latvija SIA Berlin-Chemie/Menarini Baltic Tel: +371 67103United Kingdom (Northern Ireland) A. Menarini Farmaceutica Internazionale S.R.L. Tel: +44 (0)1628 856This leaflet was last revised in
Detailed information on this medicine is available on the European Medicines Agency web site:
Entry 1 - fullUrl = Composition/composition-en-67eb9f5d8991acd60b19f2204c2773c0
Resource Composition:
Generated Narrative: Composition composition-en-67eb9f5d8991acd60b19f2204c2773c0
Language: en
Profile: Composition (ePI)
identifier:
http://ema.europa.eu/identifier
/EU/1/13/841/001-003status: Final
type: Package Leaflet
category: Raw
date: 2022-02-16 13:28:17+0000
author: Organization ACME industry
title: TEST PURPOSES ONLY - spedra
Attesters
Mode Time Official 2022-02-16 13:28:17+0000
Entry 2 - fullUrl = MedicinalProductDefinition/mp67eb9f5d8991acd60b19f2204c2773c0
Resource MedicinalProductDefinition:
Generated Narrative: MedicinalProductDefinition mp67eb9f5d8991acd60b19f2204c2773c0
identifier:
http://ema.europa.eu/identifier
/EU/1/13/841/001-003type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: Spedra 50 mg tablets
type: Full name
part
part: nan
type: Invented name part
part
part: nan
type: Scientific name part
part
part: nan
type: Strength part
part
part: nan
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language EU EU en